96 related articles for article (PubMed ID: 23378731)
21. PACAP-38 related modulation of the cranial parasympathetic projection: A novel mechanism and therapeutic target in severe primary headache.
Akerman S; Goadsby PJ; Romero-Reyes M
Br J Pharmacol; 2024 Feb; 181(3):480-494. PubMed ID: 37706270
[TBL] [Abstract][Full Text] [Related]
22. TTF-1 expression in PACAP-expressing retinal ganglion cells.
Son YJ; Park JW; Lee BJ
Mol Cells; 2007 Apr; 23(2):215-9. PubMed ID: 17464199
[TBL] [Abstract][Full Text] [Related]
23. PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
Hoffmann J; Miller S; Martins-Oliveira M; Akerman S; Supronsinchai W; Sun H; Shi L; Wang J; Zhu D; Lehto S; Liu H; Yin R; Moyer BD; Xu C; Goadsby PJ
Pain; 2020 Jul; 161(7):1670-1681. PubMed ID: 32142016
[TBL] [Abstract][Full Text] [Related]
24. Dedifferentiated Schwann cells promote perineural invasion mediated by the PACAP paracrine signalling in cervical cancer.
Chen G; Zheng Z; Sun H; You J; Chu J; Gao J; Qiu L; Liu X
J Cell Mol Med; 2023 Dec; 27(23):3692-3705. PubMed ID: 37830980
[TBL] [Abstract][Full Text] [Related]
25. PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model.
Bernard K; Dickson D; Anglin BL; Leandro Heien M; Polt R; Morrison HW; Falk T
Neurosci Lett; 2024 Jun; ():137883. PubMed ID: 38914278
[TBL] [Abstract][Full Text] [Related]
26. Integrated Transcriptomic and Proteomic Study of the Mechanism of Action of the Novel Small-Molecule Positive Allosteric Modulator 1 in Targeting PAC1-R for the Treatment of D-Gal-Induced Aging Mice.
Liang L; Chen S; Su W; Zhang H; Yu R
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612681
[TBL] [Abstract][Full Text] [Related]
27. Two distinct pathways regulate chromaffin cell exocytosis.
Short B
J Gen Physiol; 2023 Feb; 155(2):. PubMed ID: 36661929
[TBL] [Abstract][Full Text] [Related]
28. PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children.
Jovanovic T; Norrholm SD; Davis J; Mercer KB; Almli L; Nelson A; Cross D; Smith A; Ressler KJ; Bradley B
Mol Psychiatry; 2013 Jul; 18(7):742-3. PubMed ID: 22776899
[No Abstract] [Full Text] [Related]
29. Circulating PACAP levels are associated with altered imaging measures of entorhinal cortex neurite density in posttraumatic stress disorder.
Granger SJ; May V; Hammack SE; Akman E; Jobson SA; Olson EA; Pernia CD; Daskalakis NP; Ravichandran C; Carlezon WA; Ressler KJ; Rauch SL; Rosso IM
medRxiv; 2023 Aug; ():. PubMed ID: 37693514
[TBL] [Abstract][Full Text] [Related]
30. Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression.
Hu Y; Zhao M; Wang H; Guo Y; Cheng X; Zhao T; Wang H; Zhang Y; Ma Y; Tao W
J Nanobiotechnology; 2023 Aug; 21(1):261. PubMed ID: 37553718
[TBL] [Abstract][Full Text] [Related]
31. Role of pituitary adenylate cyclase-activating polypeptide in peripheral nerve regeneration: a cellular and molecular perspective.
Maugeri G; D'Agata V
Neural Regen Res; 2024 Jul; 19(7):1429-1430. PubMed ID: 38051881
[No Abstract] [Full Text] [Related]
32. PAC
Tasma Z; Siow A; Harris PWR; Brimble MA; O'Carroll SJ; Hay DL; Walker CS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430275
[TBL] [Abstract][Full Text] [Related]
33. Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP.
Fan G; Tao Z; Chen S; Zhang H; Yu R
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):657-672. PubMed ID: 35593471
[TBL] [Abstract][Full Text] [Related]
34. A Review on the Role of Endogenous Neurotrophins and Schwann Cells in Axonal Regeneration.
Pandey S; Mudgal J
J Neuroimmune Pharmacol; 2022 Dec; 17(3-4):398-408. PubMed ID: 34843075
[TBL] [Abstract][Full Text] [Related]
35. Effects of Pacap on Schwann Cells: Focus on Nerve Injury.
Maugeri G; D'Amico AG; Musumeci G; Reglodi D; D'Agata V
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153152
[TBL] [Abstract][Full Text] [Related]
36. Molecular and cellular correlates of human nerve regeneration: ADCYAP1/PACAP enhance nerve outgrowth.
Baskozos G; Sandy-Hindmarch O; Clark AJ; Windsor K; Karlsson P; Weir GA; McDermott LA; Burchall J; Wiberg A; Furniss D; Bennett DLH; Schmid AB
Brain; 2020 Jul; 143(7):2009-2026. PubMed ID: 32651949
[TBL] [Abstract][Full Text] [Related]
37. Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.
Sundrum T; Walker CS
Br J Pharmacol; 2018 Nov; 175(21):4109-4120. PubMed ID: 28977676
[TBL] [Abstract][Full Text] [Related]
38. FK962 induces neurite outgrowth in cultured monkey trigeminal ganglion cells.
Nakajima E; Walkup RD; Shearer TR; Azuma M
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):107-112. PubMed ID: 27778122
[TBL] [Abstract][Full Text] [Related]
39. PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures.
Castorina A; Waschek JA; Marzagalli R; Cardile V; Drago F
PLoS One; 2015; 10(2):e0117799. PubMed ID: 25658447
[TBL] [Abstract][Full Text] [Related]
40. PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells.
Walker CS; Sundrum T; Hay DL
Br J Pharmacol; 2014 Mar; 171(6):1521-33. PubMed ID: 24303997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
